Speech Treatment for Minimally Verbal Children With ASD and CAS
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-18
SponsorMGH Institute of Health Professions
About this trial
Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.
Eligibility criteria
Qualifiers
Meets criteria for Autism Spectrum Disorder
Able to correctly repeat at least 2 syllables
Meets criteria for Childhood Apraxia of Speech
Lives in an environment where child is exposed to English at least 50% of the time
Disqualifiers
Poorly controlled seizures
Factors such as blindness or deafness that contribute to minimally verbal status
Lives in an environment where English is not spoken at least 50% of the time
Child experiences behavioral challenges that preclude participation in the study
Trial design
Treatments tested in this trial
- CAS Treatment for Minimally Verbal Children with Autism
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov